2582. Real-World Analysis of the Outcomes of Patients Treated with Ceftazidime-Avibactam

BACKGROUND: Ceftazidime-avibactam (CAZAVI) is a novel β-lactam/β-lactamase inhibitor combination with activity against Pseudomonas aeruginosa and some carbapenem-resistant Enterobacterales. CAZAVI has been particularly useful as a carbapenem-sparing strategy to mitigate the selection pressure observ...

Descripción completa

Detalles Bibliográficos
Autores principales: Wazzi-Mkahal, Rayyan, Mansour, Reem, Hamade, Mahdi, Ghoussaini, Racha, Tashman, Adeeb, Doumat, George, Abou-Fayad, Antoine, Matar, Ghassan, Kanj, Souha S, Kanafani, Zeina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679109/
http://dx.doi.org/10.1093/ofid/ofad500.2197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679109/
http://dx.doi.org/10.1093/ofid/ofad500.2197

Ejemplares similares